Simultaneous pancreas and kidney transplants offer significant therapeutic advantages but present a diagnostic approach dilemma in the diagnosis of rejection.
| INTRODUC TI ON
Results in simultaneous pancreas kidney (SPK) transplantation continue to improve with regard to both patient and allograft survival rates, due to lower incidence of technical failure as well as improved immunosuppression protocols. 1 However, rejection remains a challenge, and its occurrence in either organ leads to a significantly higher likelihood of shortened graft survival to less than 5 years after transplantation. 2 Because both organs are from the same donor, it is generally expected that rejection would affect both organs either simultaneously or sequentially, 3-8 but this has not been shown to always be the case. [9] [10] [11] Because timing of the diagnosis of acute rejection is of crucial importance, the establishment of a protocol that maximizes diagnostic accuracy and efficacy is important. In the setting of SPK, this is also essential because the laboratory markers for suspected kidney rejection (increase in serum creatinine) are overall considered more reliable than the ones for pancreas rejection (increase in lipase and amylase). 8 Also added to these concerns are the perceived simplicity and safety of kidney allograft biopsy, as contrasted to the hazards attributed to the pancreas allograft biopsy.
The kidney has, therefore, been used by most transplant teams as a mirror or sentinel of the pancreas assessment for monitoring acute rejection in both organs. 8, [12] [13] [14] [15] Animal studies have strengthened this approach by showing significant concurrence of rejection in both organs, and also by challenging the idea that the pancreas is more prone to rejection than the kidney is. 3, 7 On the other hand, large clinical studies of truly concurrent biopsies of both organs are lacking. The current study addresses this question in a set of biopsies that were collected simultaneously in a prospective manner, when one or both organs showed dysfunction. The clinical findings were correlated with the presence, type, and degree of acute rejection, in addition to chronic rejection and other nonrejection-related pathologies in either organ, in order to determine the potential usefulness of each organ to be a potential surrogate for rejection in the other.
| MATERIAL S AND ME THODS
A total of 322 pancreas transplants were performed at our center from October 2006 to date (293 SPK transplants, 14 pancreas after kidney transplants, and 15 pancreas transplants alone). Standard immunosuppression includes induction with steroids and thymoglobulin (7.5 mg/kg) and maintenance therapy with tacrolimus, sodium mycophenolate, and steroids. Regarding operative technique, both organs were placed intraperitoneally, using the right iliac vessels for the pancreas and left iliac vessels for the kidney. Most of the time, the pancreas was placed with the head down. We routinely used systemic endocrine drainage in all cases. For exocrine drainage, we used bladder drainage at the beginning of the series and shifted gradually to enteric drainage, which represented more than 70% of the cases.
After obtaining institutional review board (IRB) approval, a retrospective review of a prospectively collected database was performed. Between November 2011 and July 2017, 70 patients required biopsy evaluation for graft dysfunction. As per our protocol, both the pancreas and the kidney were biopsied if abnormal function developed in either or both organs. Kidney dysfunction was defined as an unexplained raise in serum creatinine (≥20% above baseline), and/or the presence of significant proteinuria (≥1 g/24 hours) in enteric drained pancreas transplants. Pancreas dysfunction was defined as hyperglycemia (fasting hyperglycemia or impaired OGTT) and/or elevated pancreatic enzymes (≥100% above baseline).
Simultaneous biopsies of both organs were obtained, preferentially by laparoscopy as described previously. 16 In a minority of cases (7.2%), the biopsies were obtained at the time of laparotomy.
Of 106 biopsy attempts, adequate samples for both the pancreas and the kidney were obtained in 101 instances. We excluded from this study cases with inadequate biopsies for one or both organs, cases of surveillance/protocol biopsies (normal graft function in both organs) biopsies performed in PTA, PAK, or PASPK (pancreas transplant alone, pancreas after kidney, or pancreas after simultaneous pancreas kidney, respectively) transplants.
Tissue adequacy was judged according to the previously published
Banff guidelines, and the same guidelines were used for histologic evaluation and diagnosis of rejection, including routine performance of C4d stain (immunohistochemistry on paraffin embedded sections).
17-21
Determination of agreement (concordance) for acute rejection included assessment of degree of severity according to the kidney and pancreas Banff grading schemas. For statistical analysis, the data were analyzed with the Fisher´s exact probability test (2 by 2 contingency tables, 2-tailed). In addition, standard studies for diagnostic tests were done to calculate sensitivity, specificity, as well as positive and negative predictive values. 
| RE SULTS

| Patient population
| Kidney dysfunction group
Among the 47 patients with kidney dysfunction, 21 patients had kid- 
| Pancreas dysfunction group
Biopsies for pancreas only dysfunction were performed in 31 cases. 
Kidney rejection was found in 11 cases (35%). According to the
| Dysfunction of both grafts group
We have performed simultaneous biopsies in 23 cases with dysfunction of both grafts. Kidney rejection was found in 10 cases (43%). 
| Incidence of rejection and analysis of sensitivity and specificity of dysfunction variables
Overall there were 57 cases with rejection among the 101 biopsies (56.5%). Kidney dysfunction (with or without pancreas dysfunction) was present in 70 cases because of a rise in creatinine (65) or proteinuria over 1 g/L in enteric drained patients. 9 When kidney dysfunction was present, kidney rejection was found in 44% of the cases, with a sensitivity of 74% and a specificity of 34%. In addition, in this setting pancreas rejection was found in 30% of the cases with a sensitivity of 55% and a specificity of 22% (Table 2) .
Pancreas dysfunction (with or without kidney dysfunction) was present in 54 cases because of elevated pancreatic enzymes (31) or hyperglycemia (27) . When pancreas dysfunction was present, kidney rejection was found in 39% of the cases, with a sensitivity of 50% and a specificity of 44%. In addition, in this setting, pancreas rejection was found in 57% of the cases with a sensitivity of 82% and a specificity of 63% (Table 2) . For pancreas dysfunction, there was no difference in the incidence of pancreas rejection when the reason for biopsy was hyperglycemia (63%) vs elevated enzymes (55%) (P = NS).
Combined kidney and pancreas dysfunction was present in 23
cases. Kidney rejection was found in 43% of them, with a sensitivity of 24% and a specificity of 78%, and pancreas rejection was found in 61%
of them, with a sensitivity of 37% and a specificity of 86% (Table 2 ).
| Analysis of concordance of rejection and types of rejection
Overall there were 80 graft rejections in 57 patients. There were 19 patients with kidney only rejection, 15 patients with pancreas only rejection, and 23 patients with rejection of both grafts ( TA B L E 2 Correlation between organ dysfunction and rejection F I G U R E 1 Kidney-pancreas acute rejection incidence, concordance, and severity. In most instances (n = 44) neither organ showed rejection. Isolated kidney or pancreas rejection occurred in 19 and 15 cases, respectively. The 23 cases with simultaneous kidney and pancreas rejection displayed a higher degree of rejection in the pancreas or in the kidney in 7 and 6 instances, respectively. Ten biopsy sets showed the same degree of rejection. Cases with more severe rejection in the kidney than in the pancreas corresponded to either higher degree of TCMR (50%) or to the occurrence of concurrent AMR (50%) The concordance rate varied widely among groups, as well as with which was the rejected organ, when only one organ was rejected. In the "kidney only" dysfunction group, concordance of rejection was observed in only 22% of sets, with discordant rejections predominantly consisting of kidney only rejection (70%) with rare pancreas only rejection (8%).
In the "pancreas only" dysfunction group, concordance of rejection was observed in 47% of sets. The discordant rejections consisted mostly of pancreas only rejection (42%) with a minority being kidney only rejection (11%). In the group with dysfunction in both organs, concordance of rejection was found in 60% of sets. The discordant rejections included more pancreas only rejections (33%) than kidney only rejections (7%) (Figure 2 ).
Acute rejection was present in both organs in 23 biopsy sets of which 10 had the same degree of severity in both organs and 13
had different degrees of severity of rejection among the 2 organs.
In 7 cases, rejection was more severe in the pancreas, whereas in 6
cases it was more severe in the kidney (3 TCMR only and 3 combined TCMR and AMR). (Figure 1 ).
Analysis of rejection type (ie, TCMR vs AMR) and grade (ie, mild
TCMR vs moderate-severe TCMR) in the kidney only, kidney and pancreas, and pancreas only rejection groups showed that the incidence of AMR was more or less equally distributed among these groups (16%, 17.5%, and 13.5%, respectively; Figure 3 ). In contrast, the highest grades of TCMR (moderate-severe) were observed only in the pancreas grafts in the setting of either concordant kidney and pancreas rejection (17.5%) or pancreas only rejection (13.5%) (Figure 3 ). This finding could indicate that either the cases of concordant rejection are more severe and thus more extensive in their tissue distribution and/or the pancreas may be more "rejection prone." Two cases of discordant rejection findings are illustrated in 
| Correlation of kidney rejection with pancreas rejection
The sensitivity, specificity, and positive and negative predictive values of the kidney biopsy results for the corresponding pancreas biopsy varied significantly depending on the presence or absence of pancreas dysfunction (Table 3) .
Based on these results, an algorithm was devised for predicting pancreas rejection using the kidney biopsy and pancreas dysfunction data ( Figure 5 ). Accordingly, a positive kidney biopsy would correctly predict pancreas rejection in 86% of the cases if there is concurrent pancreas dysfunction, but only in 24% of the cases in its absence.
A kidney biopsy negative for rejection would correctly predict absence of rejection in the pancreas in 92% of the cases when there was no evidence of pancreas dysfunction, but only in 61% of cases if there is concurrent pancreas dysfunction.
| D ISCUSS I ON
In pancreas transplantation there is no reliable noninvasive labora- This study is the first to report the results of simultaneous kidney and pancreas biopsies done per protocol in the setting of any organ dysfunction. These set of biopsies can therefore show the incidence of rejection and concordance among grafts in different dysfunction
settings. This material allowed us to calculate the sensitivity and specificity of kidney and of pancreas dysfunction for rejection. Not surprisingly, kidney dysfunction has good sensitivity for kidney rejection (74%) and low sensitivity for pancreas rejection (55%). In contrast, pancreas dysfunction has low sensitivity for kidney rejection (50%) and high sensitivity for pancreas rejection (82%). However, specificity of neither of them has been sufficiently high to justify avoiding a biopsy for diagnosis.
Regarding the analysis of concordance, we decided to include only the cases with rejection, as they reflect the true incidence of concordant and discordant rejection. When no rejection cases are counted as concordant findings, concordance is therefore dependent on the incidence of rejection. In our series, we found that concordant rejection was present in 40% of the cases and discordant rejection in 60%. Concordant rejection was more frequent when both organs had dysfunction (60%) in comparison with when only the pancreas (47%) or only the kidney had dysfunction (22%).
In addition, even for the cases where concordant rejection was found, there was a discordant type or discordant degree of rejection in 56.5%. Among these patients, pancreas rejection was more severe in 54%; therefore treatment according to kidney rejection only findings would have been incomplete for the pancreas in these cases.
This prospective series of patients provides new and interesting data to help answer the question of which organ to biopsy when the patient presents with either kidney or pancreas dysfunction, or both. on the graft could impact the decision the treatment as well. For instance, a patient with hyperglycemia was found to have a TCMR grade 1A on the kidney with severe chronic damage on the pancreas.
After treatment for kidney rejection, the persistence of hyperglycemia was characterized as a pancreas failure and no further treatment was added. On another case, a "normal" pancreas on appearance (neither chronic damage nor acute inflammation) on a patient with sudden onset of diabetes symptoms 6 years after transplant was then diagnosed as recurrence of autoimmune diabetes.
Our results indicate further a potentially true biologic difference in the way kidney and pancreas are rejected. The fact that higher degrees of TCMR were observed only in the pancreas, in cases of concordant or pancreas only rejection, as well as the overall rejection grade of discrepancies being more often in disfavor of the pancreas, point to a liability of the pancreas if the kidney with its particular histology and biology is used as mirror/sentinel for the significantly different pancreas having potentially higher propensity for immunological injury. and only one graft loss reported in more than 1000 cases. Our group has recently reported the technique, yield, and safety of the laparoscopic approach with results comparable to these percutaneous series. 16 In conclusion, pancreas biopsies in experienced hands have been proved to be safe and reliable with different techniques. SPK transplant patients with graft dysfunction benefit from simultaneous pancreas and kidney biopsies, as discordant rejection is found in up to 60% of the patients with rejection. In addition, in patients with concordant rejection, discordant types and degree of rejection are found in half of these patients. Pancreas tissue when available also provides important information regarding the chronicity of the graft and the presence of other entities.
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